Published in Clin Oncol (R Coll Radiol) on August 01, 2004
Breast cancer metastasis to the central nervous system. Am J Pathol (2005) 3.30
Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst (2008) 2.24
Breast cancer subtypes and survival in patients with brain metastases. Breast Cancer Res (2008) 1.95
Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res (2009) 1.36
Clinical management of women with metastatic breast cancer: a descriptive study according to age group. BMC Cancer (2006) 1.14
New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer. Nat Clin Pract Oncol (2008) 0.99
Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies. Eur J Cancer (2010) 0.98
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases. Br J Cancer (2011) 0.96
A subset of breast cancer predisposes to brain metastasis. Med Mol Morphol (2011) 0.91
An institutional retrospective analysis of 93 patients with brain metastases from breast cancer: treatment outcomes, diagnosis-specific prognostic factors. Int J Mol Sci (2012) 0.83
Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism. Oncogene (2015) 0.82
Effect of age and biological subtype on the risk and timing of brain metastasis in breast cancer patients. PLoS One (2014) 0.82
Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer. PLoS One (2015) 0.80
Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer. Int J Clin Exp Pathol (2014) 0.78
Detection of prognostic factors in metastatic breast cancer. J Res Med Sci (2013) 0.78
Expression of Yes-associated protein (YAP) in metastatic breast cancer. Int J Clin Exp Pathol (2015) 0.78
Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: an immunohistochemical analysis. J Transl Med (2015) 0.77
Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer. Breast Cancer Res Treat (2013) 0.77
Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case Presentation. Cureus (2015) 0.77
Site-specific metabolic phenotypes in metastatic breast cancer. J Transl Med (2014) 0.77
Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosis. Exp Ther Med (2010) 0.77
Temporal effects of vascular endothelial growth factor and 3,5-cyclic monophosphate on blood-brain barrier solute permeability in vivo. J Neurosci Res (2014) 0.76
Identification of breast cancer patients with a high risk of developing brain metastases: a single-institutional retrospective analysis. BMC Cancer (2014) 0.76
Brain Metastases of Her2-Positive Breast Cancer: A Case of 34 Months' Remission with Lapatinib plus Capecitabine. Case Rep Oncol (2014) 0.75
Differential Site-Based Expression of Pentose Phosphate Pathway-Related Proteins among Breast Cancer Metastases. Dis Markers (2017) 0.75
Methods and results of local treatment of brain metastases in patients with breast cancer. Contemp Oncol (Pozn) (2017) 0.75
Radiotherapy of brain metastases from breast cancer: Treatment results and prognostic factors. Oncol Lett (2016) 0.75
Expression of reactive oxygen species-related proteins in metastatic breast cancer is dependent on the metastatic site. Int J Clin Exp Pathol (2014) 0.75
Waiting time for radiation therapy after breast-conserving surgery in early breast cancer: a retrospective analysis of local relapse and distant metastases in 615 patients. Eur J Med Res (2016) 0.75
Cranial computed tomographic findings in Nigerian women with metastatic breast cancer. Niger Med J (2013) 0.75
Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis (1994) 4.89
A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene (2006) 3.21
Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. J Pathol (2003) 3.14
Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast (2008) 2.96
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment. J Clin Oncol (2002) 2.86
Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet (2004) 2.63
Impacts of the medical malpractice slowdown in Los Angeles County: January 1976. Am J Public Health (1979) 2.56
Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology (2002) 2.35
The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol (1993) 2.27
Hospital care by hospital-based and clinic-based faculty: a prospective, controlled trial. Arch Intern Med (2001) 2.23
Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study. Eur J Cancer (2001) 2.16
High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res (2001) 2.07
Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol (1993) 1.99
Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. Br J Cancer (2004) 1.97
Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. Eur J Cancer (2007) 1.94
Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology (1995) 1.90
Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results. Eur J Cancer (2003) 1.90
Best Practice No 176: Updated recommendations for HER2 testing in the UK. J Clin Pathol (2004) 1.90
Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement. Mod Pathol (2000) 1.88
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer (2013) 1.85
Reading the prognosis of the individual with breast cancer. Eur J Cancer (2007) 1.83
Screening interval breast cancers: mammographic features and prognosis factors. Radiology (1996) 1.82
Detailed structural characterization of succinoglycan, the major exopolysaccharide of Rhizobium meliloti Rm1021. J Bacteriol (1994) 1.76
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Endocr Relat Cancer (2005) 1.75
Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers. Oncogene (2006) 1.74
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods. J Clin Pathol (2011) 1.73
X-ray refraction effects: application to the imaging of biological tissues. Br J Radiol (2003) 1.73
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia (2006) 1.69
The impact of core-biopsy on pre-operative diagnosis rate of screen detected breast cancers. Clin Radiol (1996) 1.64
Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed (1997) 1.63
Protein kinase C activation by cis-fatty acid in the absence of Ca2+ and phospholipids. J Biol Chem (1986) 1.59
Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease? J Med Screen (2001) 1.58
Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants. Arch Dis Child Fetal Neonatal Ed (1997) 1.58
Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol (1991) 1.57
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
Discrepancy between laboratory determination and visual estimation of blood loss during normal delivery. Eur J Obstet Gynecol Reprod Biol (1991) 1.47
Bacterial contaminated breast milk and necrotizing enterocolitis in preterm twins. J Hosp Infect (1995) 1.45
C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. Br J Cancer (1996) 1.44
Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal women. Eur J Cancer (2010) 1.43
Renal and diaphragmatic endometriosis de novo associated with hormone replacement therapy. J Urol (1995) 1.42
Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma. Br J Surg (2001) 1.41
Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer (2003) 1.40
A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg (2008) 1.40
Male breast cancer: a review of clinical management. Breast Cancer Res Treat (2006) 1.38
Percutaneous mitral balloon valvotomy in a patient with coexistent mitral stenosis and hypertrophic cardiomyopathy. Clin Cardiol (1993) 1.38
Varicella exposure in a neonatal intensive care unit: emergency management and control measures. J Hosp Infect (1996) 1.38
In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am J Surg Pathol (1994) 1.33
Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer. Br J Cancer (2004) 1.31
Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytology. Aust N Z J Surg (1996) 1.26
Technical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.25
c-erbB-4 protein expression in human breast cancer. Br J Cancer (2000) 1.25
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25
Pathological prognostic factors in breast cancer. Crit Rev Oncol Hematol (1999) 1.25
Intrachain disulfide bond in the core hinge region of human IgG4. Protein Sci (1997) 1.24
Potentiation of warfarin anticoagulation by topical methylsalicylate ointment. J R Soc Med (1989) 1.24
Preoperative assessment of prognostic factors in breast cancer. J Clin Pathol (2001) 1.23
Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer (2005) 1.23
Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer. Br J Cancer (2003) 1.23
Alloantigen-reactive Th1 development in IL-12-deficient mice. J Immunol (1998) 1.23
HER2 testing in the UK: further update to recommendations. J Clin Pathol (2008) 1.22
Impact of a national external quality assessment scheme for breast pathology in the UK. J Clin Pathol (2006) 1.22
IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J Immunol (1996) 1.22
Extensive summer water pulses do not necessarily lead to canopy growth of Great Basin and northern Mojave Desert shrubs. Oecologia (2003) 1.21
The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome. J Pathol (2004) 1.21
Spindle cell carcinoma of the breast: a case series of a rare histological subtype. Eur J Surg Oncol (2003) 1.21
Metaplastic carcinoma of the breast arising within complex sclerosing lesion: a report of five cases. Histopathology (2000) 1.20
An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. J Pathol (1999) 1.20
Infection control for SARS in a tertiary neonatal centre. Arch Dis Child Fetal Neonatal Ed (2003) 1.19
Overview of tyrosine kinase inhibitors in clinical breast cancer. Endocr Relat Cancer (2005) 1.19
Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum (2000) 1.19
Breast cancer diagnosis using scattered X-rays. J Synchrotron Radiat (2000) 1.18
Primary structure and mRNA localization of protein F1, a growth-related protein kinase C substrate associated with synaptic plasticity. EMBO J (1987) 1.18
E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology (2005) 1.17
Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells. J Immunol (1997) 1.17
Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology (1995) 1.17
Fulvestrant - a novel endocrine therapy for breast cancer. Curr Med Chem (2010) 1.16
E-cadherin as a prognostic indicator in primary breast cancer. Br J Cancer (2001) 1.15
Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome. Leukemia (2003) 1.15
Human papillomaviruses in 91 oral cancers from Indian betel quid chewers--high prevalence and multiplicity of infections. Int J Cancer (1995) 1.14
Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up. Hum Pathol (1998) 1.14
High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res (2000) 1.14